Cargando…
Synthesis, Biological Evaluation, and Pharmacokinetic Study of Novel Liguzinediol Prodrugs
Liguzinediol (LZDO) ester prodrugs 3–5 were synthesized and evaluated in vitro and in vivo for their potential use in prolonging the half-life of the parent drug LZDO (1a) in vivo. Prodrugs 3–5 were found to display a potent positive inotropic effect on the myocardium, without the risk of arrhythmia...
Autores principales: | Liu, Zheng, Li, Wei, Wen, Hong-Mei, Bian, Hui-Min, Zhang, Jing, Chen, Lei, Chen, Long, Yang, Kun-Di |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270099/ https://www.ncbi.nlm.nih.gov/pubmed/23599014 http://dx.doi.org/10.3390/molecules18044561 |
Ejemplares similares
-
Synthesis and Biological Evaluation of Liguzinediol Mono- and Dual Ester Prodrugs as Promising Inotropic Agents
por: Zhang, Jing, et al.
Publicado: (2014) -
The protective effects of liguzinediol on congestive heart failure induced by myocardial infarction and its relative mechanism
por: Chen, Qi, et al.
Publicado: (2020) -
PSMA-Oriented Target Delivery of Novel Anticancer Prodrugs: Design, Synthesis, and Biological Evaluations of Oligopeptide-Camptothecin Conjugates
por: Xu, Bing, et al.
Publicado: (2018) -
Synthesis, Biological Evaluation and Low-Toxic Formulation Development of Glycosylated Paclitaxel Prodrugs
por: Mao, Yukang, et al.
Publicado: (2018) -
Understanding the pharmacokinetics of prodrug and metabolite
por: Cho, Seungil, et al.
Publicado: (2018)